Current Challenges and Advances in Atherosclerosis
This reprint focuses on research on atherosclerosis. Atherosclerosis causes catastrophic thrombotic cardiovascular events, threatening not only individual healthy longevity but also socio-financial burden for the infrastructural emergent medical system. In the field of cardiovascular medicine, ather...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 03978namaa2201009uu 4500 | ||
|---|---|---|---|
| 001 | doab112467 | ||
| 003 | oapen | ||
| 005 | 20230808 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 230808s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036577302 | ||
| 020 | |a 9783036577319 | ||
| 020 | |a books978-3-0365-7731-9 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7731-9 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MBG |2 bicssc | |
| 720 | 1 | |a Ishigami, Tomoaki |4 edt | |
| 720 | 1 | |a Ishigami, Tomoaki |4 oth | |
| 245 | 0 | 0 | |a Current Challenges and Advances in Atherosclerosis |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 online resource (178 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a This reprint focuses on research on atherosclerosis. Atherosclerosis causes catastrophic thrombotic cardiovascular events, threatening not only individual healthy longevity but also socio-financial burden for the infrastructural emergent medical system. In the field of cardiovascular medicine, atherosclerosis has the largest number of patients and is an important disease that determines healthy life expectancy. There is currently no other way to control the disease than to maximize the use of medical resources and save lives. It has been clarified that local and systemic inflammation, along with risk factors, are closely related to the etiology of atherosclerosis. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medical equipment and techniques |2 bicssc | |
| 653 | |a albuminuria | ||
| 653 | |a arterial stiffness | ||
| 653 | |a atherosclerosis | ||
| 653 | |a atrial fibrillation ablation | ||
| 653 | |a atrial fibrillation and stroke | ||
| 653 | |a biomarkers | ||
| 653 | |a blood pressure change | ||
| 653 | |a cancer | ||
| 653 | |a cardiac troponin | ||
| 653 | |a cardiovascular disease | ||
| 653 | |a childhood | ||
| 653 | |a cholesterol efflux capacity | ||
| 653 | |a circular RNA | ||
| 653 | |a commensal microbiota | ||
| 653 | |a coronary heart disease | ||
| 653 | |a cryptogenic stroke | ||
| 653 | |a cuff-oscillometric | ||
| 653 | |a diabetes | ||
| 653 | |a diabetes mellitus | ||
| 653 | |a diabetic nephropathy | ||
| 653 | |a direct oral anticoagulant | ||
| 653 | |a handgrip strength | ||
| 653 | |a high-density lipoprotein | ||
| 653 | |a home blood pressure | ||
| 653 | |a immunohistochemistry | ||
| 653 | |a immunology | ||
| 653 | |a inflammation | ||
| 653 | |a isolated distal deep vein thrombosis | ||
| 653 | |a isolated high home systolic blood pressure | ||
| 653 | |a major adverse cardiovascular events | ||
| 653 | |a micro RNA | ||
| 653 | |a myosin heavy chain | ||
| 653 | |a National Institute of Health Stroke Scale score | ||
| 653 | |a network meta-analysis | ||
| 653 | |a non-invasive | ||
| 653 | |a obesity | ||
| 653 | |a patent foramen ovale and stroke | ||
| 653 | |a percutaneous coronary intervention | ||
| 653 | |a periprocedural anticoagulant management | ||
| 653 | |a potential therapeutic treatments | ||
| 653 | |a prediction | ||
| 653 | |a regulatory T cells | ||
| 653 | |a repeated measurements | ||
| 653 | |a severity of stroke | ||
| 653 | |a SGLT2 inhibitors | ||
| 653 | |a smooth muscle cells | ||
| 653 | |a stiffness | ||
| 653 | |a systematic review | ||
| 653 | |a three-vessel disease | ||
| 653 | |a type 2 diabetes | ||
| 653 | |a vascular | ||
| 653 | |a vitamin-K antagonist | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/112467 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/7582 |7 0 |z Open Access: DOAB, download the publication |